↓ Skip to main content

MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer

Overview of attention for article published in Frontiers in Genetics, January 2011
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
1 X user
peer_reviews
1 peer review site

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
22 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MicroRNAs as New Characters in the Plot between Epigenetics and Prostate Cancer
Published in
Frontiers in Genetics, January 2011
DOI 10.3389/fgene.2011.00062
Pubmed ID
Authors

Alessio Paone, Roberta Galli, Muller Fabbri

Abstract

Prostate cancer (PCA) still represents a leading cause of death. An increasing number of studies have documented that microRNAs (miRNAs), a subgroup of non-coding RNAs with gene regulatory functions, are differentially expressed in PCA respect to the normal tissue counterpart, suggesting their involvement in prostate carcinogenesis and dissemination. Interestingly, it has been shown that miRNAs undergo the same regulatory mechanisms than any other protein coding gene, including epigenetic regulation. In turn, miRNAs can also affect the expression of oncogenes and tumor suppressor genes by targeting effectors of the epigenetic machinery, therefore indirectly affecting the epigenetic controls on these genes. Among the genes that undergo this complex regulation, there is the androgen receptor (AR), a key therapeutic target for PCA. This review will focus on the role of epigenetically regulated and epigenetically regulating miRNAs in PCA and on the fine regulation of AR expression, as mediated by this miRNA-epigenetics interaction.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 5%
Belgium 1 5%
Canada 1 5%
Unknown 19 86%

Demographic breakdown

Readers by professional status Count As %
Researcher 8 36%
Other 4 18%
Professor > Associate Professor 3 14%
Student > Ph. D. Student 3 14%
Student > Master 2 9%
Other 2 9%
Readers by discipline Count As %
Agricultural and Biological Sciences 11 50%
Medicine and Dentistry 5 23%
Biochemistry, Genetics and Molecular Biology 4 18%
Immunology and Microbiology 1 5%
Unknown 1 5%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2012.
All research outputs
#14,142,788
of 22,662,201 outputs
Outputs from Frontiers in Genetics
#3,880
of 11,727 outputs
Outputs of similar age
#136,259
of 180,278 outputs
Outputs of similar age from Frontiers in Genetics
#24
of 58 outputs
Altmetric has tracked 22,662,201 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,727 research outputs from this source. They receive a mean Attention Score of 3.7. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,278 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.